Milestone Scientific Inc. MLSS 深 滬
已收盤 08-07 16:00:00 美东时间
0.4811
+0.016
+3.46%
華盛通- 最 高0.49
- 今 開0.465
- 成交量 13.08万股
- 最 低 0.4601
- 昨 收 0.465
- 總市值 4255.30万
- 52周最高 0.675
- 市盈率 靜 --
- 換手率 0.15%
- 52周最低 0.2181
- 委 比 0.00%
- 總股本 8844.94万
- 歷史最高 4.853
- 量 比 0.73
- 振 幅 6.43%
- 歷史最低 0.2181
- 每 手 1
- 風險率 0.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Milestone Scientific Directors Elect Conversion of Bridge Notes
Milestone Scientific ( ($MLSS) ) just unveiled an announcement. On July 24, 202...
07-30 05:48
Milestone Scientific expects Q2 revenue of $2.8M
Milestone Scientific (MLSS) on Wednesday said it expects total revenue of about $2.8 million for the second quarter of 2026, representing an approximate 21% increase compared to $2.3 million for the s...
07-01 20:51
Milestone Scientific Expects Q2 Revenue Of ~$2.8M, Up 21% YoY; H1 Revenue Of ~$5M, Up 9% YoY
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced preliminary, unaudited revenue for the second quarter ending June 30, 2026. The Company expects total revenue of approximately $2.8 milli...
07-01 20:35
Milestone Scientific Strengthens Board to Support Next Phase of Growth
Milestone Scientific Inc. announced strategic governance changes to support long-term growth, including Benedetta Casamento transitioning to Executive Chair and appointing Greg Shilling and Kelly Ulto as independent directors. Shilling brings expertise in healthcare technology and AI, while Ulto offers extensive experience in finance and audit. The company also restructured its agreement with founder Leonard Osser, ensuring continuity and alignme...
06-25 13:00
Milestone Scientific Notes Growing Clinical Adoption And Physician Acceptance Of Its CompuFlo Epidural System After Research Publication
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued growth in clinical
05-27 20:54
Full Transcript: Milestone Scientific Q1 2026 Earnings Call
Milestone Scientific (AMEX:MLSS) released first-quarter financial results and h...
05-14 21:11
Reported earlier, Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est
Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.
05-14 21:08
Milestone Scientific Q1 EPS $(0.01), Inline, Sales $2.162M Miss $2.252M Estimate
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.
05-14 04:02
